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Laforin or malin deficiency causes Lafora disease,
characterized by altered glycogen metabolism and
teenage-onset neurodegeneration with intractable
and invariably fatal epilepsy. Plant starches possess
small amounts of metabolically essential monophos-
phate esters. Glycogen contains similar phosphate
amounts, which are thought to originate from a
glycogen synthase error side reaction and therefore
lack any specific function. Glycogen is also believed
to lack monophosphates at glucosyl carbon C6, an
essential phosphorylation site in plant starch meta-
bolism.We now show that glycogen phosphorylation
is not due to a glycogen synthase side reaction, that
C6 is amajor glycogen phosphorylation site, and that
C6 monophosphates predominate near centers
of glycogen molecules and positively correlate
with glycogen chain lengths. Laforin or malin de-
ficiency causes C6 hyperphosphorylation, which
results in malformed long-chained glycogen that
accumulates in many tissues, causing neurodegen-
eration in brain. Our work advances the understand-
ing of Lafora disease pathogenesis and suggests
that glycogen phosphorylation has important meta-
bolic function.
INTRODUCTION
Heterotrophs and plants use glycogen and starch, respectively,
as main glucose-storing carbohydrates. Glycogen is a polydis-
perse branched macromolecule. Starch is composed of
amylose, a mostly unbranched minor component, and amylo-756 Cell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc.pectin, its branched major constituent. Amylopectin and
glycogen possess only two types of interglucose bonds, a-1,4
and a-1,6, generating helical chains and branchings, respec-
tively. In glycogen, branchings are evenly distributed, leading
to a spherical structure where glucan chains are largely hidden
within the sphere but nonreducing chain ends are exposed to
the cytosol, rendering the large molecule water soluble. In
amylopectin, branchings are clustered, leading vicinal side
chains to form double helices, neighboring double helices to
stack, and the entire starch particle to be water insoluble (Fig-
ure 1; Pe´rez and Bertoft, 2010; Roach et al., 2012).
Mammalian glycogen biosynthesis requires glycogen syn-
thase (GS) and glycogen branching (GBE) enzymes. GS repeti-
tively transfers glucosyl residues from UDPglucose to nonre-
ducing ends of a-glucan chains (chain elongation) and GBE
forms branchings. Glycogen is degraded by glycogen phosphor-
ylase (GP) and glycogen debranching enzymes (Roach et al.,
2012). Amylopectin synthesis is also based on chain elongating
and branching reactions, but various synthase and branching
isozymes (and distinct debranching enzymes) participate in
crafting the final structure. Amylopectin is degraded by the
concerted action of several hydrolytic (iso)enzymes (Zeeman
et al., 2010; Fettke et al., 2012).
Amylopectin turnover includes transitions between ordered
and less ordered states that are largely mediated by cycles of
phosphorylation (decreasing physical order) and dephosphory-
lation (permitting reorganization; Hejazi et al., 2012). Steady-
state levels of starch phosphorylation vary between plant
species and organs but are generally far less than 1 phosphate
per 100 glucosyl residues (Zeeman et al., 2010). At positions
C6 and C3, esterification is mediated by glucan, water dikinase
(GWD) and phosphoglucan, water dikinase (PWD), respectively
(Hejazi et al., 2012). Starch dephosphorylating enzymes include
Starch Excess Four (SEX4) and like-SEX4-2, both belonging
to the class of dual-specificity phosphatases (DSPs; Niittyla¨
et al., 2006; Santelia et al., 2011). Mutants lacking either
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Figure 1. Schematic Presentation of Branchings in Glycogen and Amylopectin
(A) Internal section of a branched a-glucan. R1, glucan chain at the reducing end; R2 and R3, chains at the nonreducing ends. All OH-groups are potential
monophosphorylation sites.
(B and C) Segments of glycogen and amylopectin, respectively. In glycogen, branching points are evenly distributed; in amylopectin, they are clustered.
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starch levels and growth retardation (Hejazi et al., 2012).
Glycogen also contains phosphate (Lomako et al., 1994),
which until recently was thought to play a crucial though yet-
undefined role in glycogen metabolism regulation, based on
findings in Lafora disease (LD). In LD a poorly branched and
water insoluble type of glycogen (polyglucosan) accumulates
in various tissues. In the brain, these accumulations (termed
Lafora bodies) overtake neuronal dendrites and provoke neuro-
degeneration and intractable and fatal seizures (Minassian,
2001; Turnbull et al., 2011). LD is caused by loss-of-function
mutations in genes EPM2A (laforin) or EPM2B (malin). Malin
is a ubiquitin E3 ligase which at least in part regulates laforin
levels (Gentry et al., 2005; Tiberia et al., 2012), while laforin is
a phosphatase which regulates glycogen phosphate (Worby
et al., 2006; Tagliabracci et al., 2008). In laforin-deficient mice,
glycogen acquires high phosphate levels as a prerequisite to
polyglucosan formation (Tagliabracci et al., 2008). Laforin
closely resembles the plant starch phosphatase SEX4. Both
SEX4 and laforin consist of a DSP domain and a CBM20-type
carbohydrate binding module, and laforin complements
Arabidopsis mutants lacking SEX4 (Kerk et al., 2006; Gentry
et al., 2007).
An important role for glycogen phosphorylation (and dephos-
phorylation by laforin) in glycogen metabolism regulation has
been challenged by recent results suggesting that phosphate
is introduced into glycogen merely through an error of the GS re-
action (details below; Tagliabracci et al., 2011), leading to the
current dominant view that, as opposed to starch, glycogen
phosphorylation is, per se, regulatory irrelevant, and that
dephosphorylation by laforin simply ensures correct glycogen
biosynthesis by removing the products (phosphates) of an erro-
neous GS side reaction (Roach et al., 2012).CWe present detailed analyses of wild-type (WT) and LD
glycogen, including size distribution, phosphate patterns, intra-
molecular distribution of defined phosphate esters, precise glu-
cosyl carbon phosphorylation sites, and absence of evidence for
a GS enzymatic error in glycogen phosphorylation. The results
suggest a re-evaluation of the biochemistry of glycogen phos-
phorylation and point to an essential function of glycogen modi-
fication in central carbon metabolism in humans.
RESULTS
Structural Differences between Normal and LD
Glycogen
Muscle glycogen isolated from WT, laforin-deficient, and malin-
deficient mice were analyzed by FFF-MALLS (Wyatt, 1993). Dif-
ferences in size distribution (Figure 2A) and averaged size were
observed (Figure 2B). Glycogen from laforin-deficient mice is
smaller, but that of malin-deficient mice exceeds that of the
WT control. For a more detailed analysis, a-glucans released
by exhaustive isoamylase-mediated debranching (Experimental
Procedures, debranching method 1) were separated by high-
performance anion-exchange chromatography (HPAEC-PAD).
The degree of polymerization (DP) of the linear glucans derived
from WT glycogen ranges from 2 to more than 30 glucosyl units,
with DPs of 5–15 being most prominent. Chain patterns from LD
glycogen differ, but deviations are complex: laforin-deficient
glycogen contains a high proportion of very short side chains
(DP2 and DP3). Medium-sized chains (DPs 3–13) are less
frequent, but long chains (DP R15) are more abundant than in
the control. Glycogen from malin-deficient mice is to some
extent similar to laforin deficiency but clearly deviates in the
very short chains, which are rare. Abundance of larger side
chains (DPR15) is higher than in laforin deficiency (Figure 2C).ell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc. 757
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Figure 2. Molar Masses and Chain Patterns of Muscle Glycogen in
Wild-Type and LD Mice
(A) Size distribution of muscle glycogen isolated from WT, Epm2a–/–, and
Epm2b–/– tissue as determined by FFF. Gray shadows reflect SEM (n = 6
biological replicas). Left scale, RI signals (black lines, linear scale); right scale,
molar mass (gray lines, logarithmic scale).
(B) Averaged size of the three glycogen preparations (linear scale). Error, SD.
(C) Chain patterns (HPAEC-PAD) of muscle glycogen isolated from WT,
Epm2a–/–, and Epm2b–/– tissue following exhaustive isoamylolysis. Mean
relative peak areas of each chain length (n = 6 biological replicas) are given for
WT glycogen. Dmolar percent, [areamutant  areawild-type] / areawild-type 3 100.
Error, sum of SDs from WT and mutant.
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profoundly altered.
Glucosyl 6-Phosphate Residues Are Common in
Monophosphate Patterns of Glycogen, Are Increased in
LD, and Are Hydrolyzed by Laforin
Recently in rabbit skeletal muscle glycogen, monophosphate
esters were identified at glucosyl carbons C2 and C3 but were
claimed not to exist at C6 (Tagliabracci et al., 2011). If so, phos-
phate patterns in glycogen and starch would greatly differ. In
the latter, C6 is a major phosphorylation site essential to the
(de)phosphorylation cycle and the entire starch turnover (Hejazi
et al., 2012).
To test for the reported absence of phosphorylation at C6, we
established an enzymatic assay to quantify glucose 6-phos-
phate (G6P) in glycogen (detailed in Figure 3). Glycogen isolated
from WT rabbit and mouse muscle and mouse liver was sub-758 Cell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc.jected to acid hydrolysis (Experimental Procedures, acid hydro-
lysis method 1, henceforth termed H1), and G6P released was
measured using an enzymatic cycling assay (Figures 3A–3C; Gi-
bon et al., 2002) that we adapted to the large excess of glucose
generated by hydrolysis of polyglucans (see Figure S1 online).
G6P was present in the glycogen preparations, unequivocally
(Figure 3D), except in mouse liver, where it was at the detection
limit (0.008 mmol G6P per mol glucose). To clarify the situation in
liver, we first degraded liver glycogen partially using a mixture of
a-amylase and amyloglucosidase, enriched generated phos-
phoglucans by ion exchange chromatography (Experimental
Procedures and Figure S2), and subjected these phosphoglu-
cans to acid hydrolysis (acid hydrolysis method 2, henceforth
H2). The cycling assay measured 17.7 mmol G6P per mol
glucose in this hydrolysate (Figure 3D), confirming the presence
of G6P in liver glycogen.
Using the cycling assay we also measured the G6P content of
muscle and liver glycogen from Epm2a/ and of muscle
glycogen from Epm2b/ mouse. Muscle and liver glycogen
from WT mouse served as control. G6P was over 7-fold
increased in all glycogens from the LD mice compared to WT
(Figure 3D). In vitro the elevated monophosphates at C6 were
largely hydrolyzed by laforin (Figures 3E–3G).
Pattern of Glycogen Phosphate Esters as Revealed
by NMR Analysis
We next aimed to confirm presence of phosphorylation at
glycogen C6 carbons using NMR, initially in Epm2a/ mouse
liver glycogen using curcuma starch (Schoch and Maywald,
1968; Blennow et al., 1998) as control. Samples were first enzy-
matically degraded by a mixture of amyloglucosidase and
porcine pancreatic a-amylase. The latter is known to degrade
starch to (phospho)oligoglucans with DPs below 8 (Hizukuri
et al., 1970; Posternak, 1951). Phosphoglucans derived from
these digestions were then enriched by ion-exchange chroma-
tography (for recovery, see Figure S2) and applied to NMR.
Carbon atoms were identified by 1H,13C correlations and
1H,1H-DQF-COSY spectra. Attachment of phosphate was deter-
mined using 1H,31P-HMBC spectra and confirmed by 31P-edited
1H,13C correlation (Figure 4; for details, see the Supplemental
Information). Monophosphate esters at C6 were conclusively
demonstrated in Epm2a/ liver glycogen, and as expected in
starch (Figure 4). Monophosphate esters were also present at
C3 and C2 in Epm2a/ liver glycogen, and only at C3, as antic-
ipated, in curcuma starch. Repeating these experiments withWT
rabbit muscle glycogen gave the same results (C6, C3, and C2
monoesterification; Figure S4), indicating that C6 phosphoryla-
tion is neither species nor organ specific. No phosphodiesters
were detected in any of the samples.
Uneven Distribution of Glucosyl 6-Phosphate Residues
in Glycogen
Intramolecular distribution of G6P residues in native WT mouse
muscle glycogen was determined using several approaches
(Figure 5A). First, glycogen was resolved using FFF-MALLS
into small, medium, and large size fractions whose averaged
molecular weight differs by more than one order of magnitude
(Figure 5B). Following exhaustive acid hydrolysis (H1), the
glucose-based G6P content of the three fractions was similar
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Figure 3. Glucose 6-Phosphate Content of Glycogen or Starch Hydrolysates
(A) Scheme of the three steps of the cycling assay. Enzymatic oxidation of G6P (initial analyte) and equimolar formation of NADPH (intermediate; step 1).
Subsequently, NADP+ is chemically destroyed, but NADPH is retained (step 2). NADPH is then permanently cycled, permitting a constant rate of formazan
(product; step 3) formation which is photometrically measured at 570 nm. See details in the Supplemental Experimental Procedures.
(B) Absorbance at 570 nm over time during formazan formation at different initial G6P concentrations in sample volume 25 ml.
(C) Increase in E570 plotted against the initial G6P concentration (B). The calibration curve, being strictly linear, proves validity of the assay and serves for
calculation of unknown G6P concentrations from E570 rates measured in simultaneously processed samples. Error, SD (n = 3 technical replica).
(D) Glucose-based G6P content of six hydrolyzed glycogen, three starch, and two phosphoglucans enriched from liver glycogen preparations as determined by
the cycling assay.
(E–G) In vitro dephosphorylation of 6-phosphoglucosyl residues in glycogen by laforin. Outline of the experiments (E). Glucose-based G6P content after two
incubation periods (F), and validation of the G6P measurements (G).
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Figure 4. NMR Spectra of Phosphoglucans Derived from Glycogen
and Starch
Enriched phosphoglucans of curcuma starch and Epm2a–/– mouse liver
glycogen were analyzed (Figure S2). The region of glucosyl carbon-hydrogen
correlations is shown without the anomeric range.
(A and D) multiplicity-edited 13C,1H-HSQC: gray and black signals indicate
methylene (CH2) and methine (CH) groups, respectively.
(B and E) 31P-edited 13C,1H-HSQC: signals indicate either 2JCP or
3JCP
coupling. The former proves phosphate and hydrogen linked to the same
carbon (dotted circles), while the latter occurs when hydrogen and phosphate
are bound to adjacent carbons. The assignment to either of the two possibil-
ities was obtained by high-resolution HSQC (Figure S3). The assignment of H2
and H3 is based upon 1H,1H-DQF-COSY NMR (Figure S4).
(C and F) 1H,31P-HMBC: signals indicate vicinal correlation of phosphate and
hydrogen. NMR analysis of phosphoglucans derived from rabbit muscle
glycogen identified the same phosphorylation sites (Figure S4).
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760 Cell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc.(Figure 5B), indicating that glycogen size does not noticeably
correlate with the relative G6P content. Each glycogen fraction
was then exhaustively debranched by isoamylase and chain
length distribution determined. As shown by HPAEC-PAD, the
three fractions have similar chain patterns (Figure 5C). Thus,
neither glucose-based G6P content nor chain length distribution
varies with size of native glycogen.
In a second approach, native glycogen was gradually
degraded by a-amylase, an endo-acting enzyme capable of
cleaving interglucose bonds in chains exceeding three residues
from a branch point or from a phosphoester (Posternak, 1951;
Hizukuri et al., 1970). Thus, the action of a-amylase on glycogen
is not significantly affected by branchings and essentially
not limited by the rare phosphoesters present in glycogen. At
intervals, aliquots of the reaction mixture were passed through
a 10 kDa filter, and glycogen remaining in the retentate was
further analyzed. Size distribution was determined by FFF, and
following acid hydrolysis (H1), both glucose and G6P were
quantified. During a-amylolysis, size distribution of glycogen
decreased in line with glucose content, indicating that irrespec-
tive of initial size all glycogenmolecules are degraded (Figure 6A).
Glucan chains phosphorylated at C6 are to some extent also
released by a-amylase. However, both glycogen amount and
averaged size decrease more strongly than G6P, and conse-
quently, glucose-based G6P levels increase several-fold in the
partially degraded glycogenmolecules (Figure 6B), strongly sug-
gesting that G6P residues are unevenly distributed and largely
located in interior parts of the molecules. a-amylolysis proceed-
ing from the surface to the center of glycogen was separately
confirmed by experiments using glycogen prelabeled at the
periphery (Figure S5). Furthermore, the increased glucose-
based G6P levels are not due to preferential a-amylolysis of
distinct glycogen molecule sizes, since native glycogen did not
show correlations between size distribution and glucose-based
G6P levels (see above).
Third, in a similar experiment (Figure 5A), native glycogen was
gradually debranched by isoamylase, and at intervals aliquots of
the reaction mixtures were passed through a 30 kDa filter.
Glycogen remaining in the retentate was analyzed by FFF-
MALLS or was subjected to exhaustive acid hydrolysis (H1) fol-
lowed by glucose and G6P quantification. Furthermore, aliquots
were completely debranched (Experimental Procedures, de-
branching method 2) by isoamylolysis, and chain patterns were
analyzed by HPAEC-PAD (Figure 6D). As with a-amylase, isoa-
mylase treatment results in gradually decreasing glycogen con-
tent. However, as demonstrated in two independently performed
experiments, the average glycogen size does not decrease in the
mode observed during a-amylolysis. Following decrease to 75%
within the first 10 min, the average molecule size remains largely
constant throughout the remaining incubation, while degrada-
tion progresses, as demonstrated by the further decreasing
glycogen content (Figure 6C and Figure S5C). Thus, isoamylase
appears to degrade glycogen molecules largely sequentially,
completing the debranching of one molecule before acting on
another. During isoamylolysis, chain patterns of residual
glycogenwere greatly altered. Smaller side chains were lost first,
and the remaining glycogen became enriched in longer side
chains (Figure 6D). This enrichment, occurring also at later
stages of gradual isoamylolysis, indicates that across molecule
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Figure 5. Glucosyl 6-Phosphate Residues in Glycogen
(A) Design of the experiments shown in Figures 5B and 5C and Figure 6. (Left) Size-dependent separation of native glycogen into three fractions by FFF-MALLS
and subsequent analyses. (Right) Gradual a-amylolysis and isoamylolysis of native (nonfractionated) glycogen and carbohydrate analyses following the mem-
brane filtration.
(B and C) Glycogen applied to FFF was collected in three fractions containing glycogen having low, intermediate, and high average molar mass (B). In the three
fractions, glucose-based G6P content (B) and, following exhaustive debranching, chain patterns (C) were determined. Experiments were carried out on two
individual glycogen preparations (two values ± SD of three technical replicas in B; mean relative peak area in C; error, absolute deviation).
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side chains. Interestingly, the remaining glycogen being
composed of longer side chains showed increased glucose-
based G6P content, indicating that monoesterification at C6
positively correlates with chain length. Notwithstanding, C6-
phosphorylated glucan chains are to some extent removed by
the isoamylolysis (Figure 6C).
Glycogen Phosphorylation Is Not Mediated by GS or GP
GS repetitively transfers glucosyl residues from UDPglucose
to nonreducing ends of glycogen through the following
reaction:
glycogen + UDPglucose4glycogen-glucose + UDP: (1)CRecently, it was proposed that GS infrequently, 1 out of 104
reactions, transfers a phosphoglucosyl instead of a glucosyl res-
idue, thereby incorporating the b-phosphate of UDPglucose
(U-Pa-Pb-glucose) into glycogen. At its simplest, this side reac-
tion would be
glycogen + UDPglucose4glycogen-Pb-glucose + UMPa; (2)
yielding a phosphodiester between a terminal glycogen glucosyl
carbon C4 and the transferred glucose carbon C1. Since NMR
studies performed by these authors showed C2 and C3monoes-
ters but no diesters, the following alternative reactions were
hypothesized to occur, catalyzed by GS. First, glucose 1-phos-
phate (G1P) would separate from UDPglucose (the phosphate
in G1P being the former b-phosphate of UDPglucose), andell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc. 761
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Figure 6. Distribution of G6P Residues in Wild-Type Muscle Glycogen from Mice
The experimental design is outlined in Figure 5A, right.
(A) Molar mass distributions (FFF-MALLS) of glycogen partially degraded by a-amylase but retained by the 10 kDa filter. RI signal intensities (left; linear scale) and
molar masses (right; logarithmic scale) are given.
(B) Averaged masses and amounts of glucosyl and G6P residues (each given as percentage of the initial values of glycogen; left scale) and glucose-based G6P
levels (right scale) of the partially degraded glycogen. Mean ± SD (n = 3, technical replica; one of two independent experiments for size determination).
(C) Averaged masses, amounts of glucosyl and G6P residues, and glucose-based G6P levels of glycogen retained by a 30 kDa filter during isoamylolysis (details
as in Figure 6B). While the amount of glycogen steadily decreases, the averagemolar mass decrease becomes very slow after 10 min and remains between 60%
and 80% throughout 90 min incubation, indicating a sequential mode of molecule degradation by isoamylase (Figure S5). The release of 6-phosphoglucosyl
residues takes place at much slower rate, resulting in an increase of glucose-based C6 phosphorylation in the partially degraded glycogenmolecules. Mean ± SD
(n = 3, technical replica; one of two independent experiments for size determination, see Figure S5C).
(D) During isoamylolysis, the partially degraded glycogen was subjected to a second (exhaustive) debranching prior to HPAEC-PAD analysis. The chain pattern of
partially degraded glycogen shifts toward higher DPs during gradual isoamylolysis. Together with the increased glucose-based G6P content (C), this result
indicates that G6P residues occur more frequently in glycogen regions containing longer side chains.
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bon C1 of G1P to its carbons C2 or C3, creating glucose 2-phos-
phate (G2P) or glucose 3-phosphate (G3P), which would then
covalently bind to nonreducing ends of glycogen, thus intro-
ducing the C2 and C3 monoesters into glycogen (Tagliabracci
et al., 2011).
Three types of experiments suggested this GS-mediated
transfer of the UDPglucose b-phosphate to glycogen. The
most critical consisted in incubating UDPglucose, radiolabeled
either at the glucosyl residue [14C] or at the b-phosphate [32P],
with glycogen as primer and mouse muscle extract as GS
source. Subsequently, glycogen was precipitated, subjected to
SDS-PAGE, and autoradiographed. With UDP-[U-14C]glucose,
glycogen acquired 14C, as expected. However, it also was
labeled with 32P with [b-32P]UDPglucose as glucosyl donor.
When muscle extract from mice lacking GS was used, glycogen762 Cell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc.acquired neither 14C nor 32P, suggesting that incorporation of
b-phosphate from UDPglucose into glycogen requires GS
(Tagliabracci et al., 2011).
We had performed the same experiment but, prior to SDS-
PAGE, had also removed small compounds by gel filtration using
a Sephadex G50 column (Figure 7A). When gel filtration was
omitted, the GS-deficient extract resulted in neither 14C- nor
32P-labeling of glycogen (Figure 7B), while WT extract mediated
both 14C- and 32P-labeling of glycogen, both of which were sen-
sitive to amyloglucosidase treatment. Following gel filtration,
however, 14C was retained on glycogen, while the 32P-label dis-
appeared (Figure 7B). Thus, 14C, but not 32P, is covalently bound
to glycogen.
What is this precolumn 32P-labeled contaminant, and why is
it only seen when WT extract is used? During incubation, an
extract containing GS converts 30% of [b-32P]UDPglucose to
AB C D
E
Figure 7. Phosphorylation of Glycogen Is Not Due to a Side Reaction of GS
(A) Experimental design. WT rabbit liver glycogen was incubated as indicated. Subsequently glycogen was precipitated in 66% [v/v] ethanol, dissolved in water,
and processed as indicated.
(B) Autoradiographs of PAA gels following electrophoresis of 14C- or 32P-labeled glycogen. Incubationwith amuscle extract frommice lacking GS (MGSKO) does
not result in any labeling. Amyloglucosidase treatment (AMG) of the labeled glycogen abolishes labeling. Gel filtration (Col) removes 32P but not 14C labeling.
(C) 32P-labeling of glycogen is due to noncovalent interaction of [32P]UDP with glycogen and does not require GS activity.
(D) In the presence of GS, both the 32P and the 14C labeling increase with time when gel filtration is omitted.
(E) As in (D) but including gel filtration. Over the entire incubation period, 32P is removed but 14C labeling is unchanged when glycogen is passed repetitively
through Sephadex G50.
Arrowheads mark the bottom of the wells where glycogen resides.
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Normal and Lafora Disease Glycogen[b-32P]UDP (Tagliabracci et al., 2011). Therefore, reaction mix-
tures containing WT or GS-deficient extracts differ, the former
containing an increasing level of a radioactive compound,
[b-32P]UDP, not present in the latter. The amount of phosphate
presumed to be covalently bound to glycogen is very small
(one phosphate per 104 glucose residues incorporated; Tagliab-
racci et al., 2011). Thus, one 32P appeared to be incorporated
into glycogen for every 104 [b-32P]UDP molecules generated.CIf even only one of every 104 [b-32P]UDP molecules formed
remains noncovalently associated with glycogen during the sub-
sequent analysis, it would account for the apparent 32P glycogen
labeling. What remained to be determined was whether [b-32P]
UDP has a substantially higher affinity to glycogen than [b-32P]
UDPglucose. To test this, we incubated glycogen with either
[b-32P]UDPglucose (mixture I) or a mixture consisting of 40%
[b-32P]UDP and 60% [b-32P]UDPglucose (mixture II) withell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc. 763
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GS was included in a mixture containing glycogen plus [b-32P]
UDPglucose (Figure 7C, left). Glycogen labeling was then
analyzed by SDS-PAGE and autoradiography, with the gel filtra-
tion step omitted. In the absence of GS, mixture II was more
efficient in labeling glycogen with 32P as compared to mixture I
(Figure 7C, right), confirming that UDP interacts more strongly
with glycogen than does UDPglucose.
Another experiment suggesting GS-mediated glycogen phos-
phorylation was the time-dependent increase in both 14C- and
32P-labeling of glycogen when incubated with purified GS and
either UDP-[14C]glucose or [b-32P]UDPglucose (Tagliabracci
et al., 2011). When repeating essentially the same experiment,
we obtained the same result (Figure 7D). However, when
glycogen was passed through the Sephadex G50 column gel
filtration prior to SDS-PAGE and autoradiography, 32P-labeling
always disappeared for all time points, while 14C increased
with time (Figure 7E). Thus, 32P-labeling of the glycogen sample
increases with time (provided gel filtration is omitted), reflecting
time-dependent [b-32P]UDP formation, rather than covalent
32P incorporation. Additional experimental evidence failing to
support the proposed role of GS in glycogen phosphorylation
is detailed in Figure S6.
In glycogen metabolism, the only other known enzyme acting
on phosphates is GP, through the reaction
glycogen-glucose+Pi4glycogen+glucose-1-phosphate: (3)
Through a series of experiments similar to the above, we find
no evidence for GP-mediated glycogen phosphorylation (Fig-
ure S6). Thus, glycogen phosphorylation is not mediated by
either GS or GP.DISCUSSION
Deficiency of either laforin or malin markedly and selectively af-
fects structural features of glycogen, such as size distribution,
chain length patterns, and phosphorylation. Based on both enzy-
matic and various NMR techniques, we identify glucosyl 6-phos-
phate residues as a major proportion of glycogen monophos-
phates, and confirm esterification at C2 and C3. From these
results, two conclusions are reached, first that LD is associated
with a greatly altered glycogen structure, and second that the
monophosphate pattern of glycogen is remarkably similar to
that of starch (Tabata and Hizukuri, 1971).
While monophosphates at C2 and C3 cannot be determined
selectively and sensitively, our cycling assay allows precise
quantification of G6P in the presence of high glucose levels. By
virtue of its sensitivity, the test often does not require any enrich-
ment of target compounds. Since in LD glycogen the glucose-
based G6P content is 7- to 9-fold increased, pathogenesis of
Lafora bodies and LD clearly includes hyperphosphorylation at
C6. Our results also show that C6 monophosphate esters are a
substrate of laforin.
A complex GS side reaction has been proposed to mediate
glycogen phosphorylation, but this mode is inconsistent both
with the uneven phosphate distribution within glycogen and
with esterification at C6. The hypothesized GS side reaction
requires cyclization of G1P prior to formation of a-1,4 interglu-764 Cell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc.cose bonds. For C2 phosphorylation, a five-membered cycliza-
tion was postulated to transfer the phosphate ion from C1 to
C2, and for C3 esterification a six-membered cyclization
(Tagliabracci et al., 2011). As discussed by the authors, these
cyclic structures are possible. However, seven-membered cycli-
zation, as required for transfer of phosphate from C1 to C6, is
impossible (Khorana et al., 1957).
The hypothetical GS side reaction was deduced from experi-
ments in which we now identify a previously unknown and diffi-
cult to anticipate pitfall, namely that a product of the established
GS reaction, UDP, noncovalently interacts with glycogen more
strongly than UDPglucose. Avoiding this pitfall, we find no evi-
dence of any phosphorylation of glycogen by GS (or by GP).
Rather, GS exhibits a high reaction specificity, as do starch syn-
thase isozymes from plants.
The mode or modes of the interaction between UDP and
glycogen is/are not known, and, given their noncovalent nature
is relatively variable. In retrospect, this interaction is perhaps
not surprising, considering that glycogen is a standard reagent
in molecular biology used for the purpose of facilitating the pre-
cipitation of, especially small amounts of, nucleic acids (Sam-
brook and Russell, 2001).
Given the identity of phosphorylation sites in glycogen and
starch, the uneven distribution of G6P within the glycogen
molecule, as well as structural and functional similarities
between the DSPs laforin and SEX4, the question arises
as to whether enzymology and metabolic functions of
glycogen and starch (de)phosphorylation are related. In plants,
the (de)phosphorylation cycle of amylopectin is important for
the entirety of starch metabolism (Hejazi et al., 2012). Two plas-
tidial dikinases phosphorylate amylopectin at C6 and C3,
respectively, and plastidial DSPs mediate dephosphorylation.
Deficiency of each of these enzymes leads to a complex pheno-
type including abnormally high starch levels, largely altered
phosphate levels in starch or starch degradation products, and
growth defects (for review, see Hejazi et al., 2012). Classical
glycogen biosynthesis and degradation are based on similar re-
actions as in starch metabolism (such as synthase, phosphory-
lase, branching, and debranching enzymes) and are modulated
through complex regulation of several of these enzymes (Roach
et al., 2012). Laforin is the first known DSP to dephosphorylate
glycogen. If not functional, glycogen is hyperphosphorylated
and various tissues massively accumulate a water-insoluble
form of glycogen (Tagliabracci et al., 2008; Minassian, 2001).
The brain is most severely affected, at least in part due to the
particular toxicity of excess glycogen to neurons (Duran et al.,
2012).
As glycogen phosphorylation is not mediated by any acci-
dental side reaction of established metabolizing enzymes
(GS or GP), distinct phosphorylating enzymes are postulated.
Whether a single or several kinases (or dikinases) mediate(s)
esterification of the three carbons remains uncertain, but for ste-
ric reasons, we favor the latter possibility. In any case, our results
suggest that glycogen phosphorylation is a physiological and
regulatory-relevant process. Regulation of laforin activity by pro-
tein phosphorylation (Roma´-Mateo et al., 2011) is consistent with
this view. In laforin deficiency, the massive disturbance of
glycogen metabolism develops over time, apparently requiring
many cycles of glycogen turnover before becoming manifest. A
Cell Metabolism
Normal and Lafora Disease Glycogensimilar deterioration with time occurs with SEX4-deficient plants
(Ko¨tting et al., 2009).
Higher glycogen phosphorylation in LD is associated with
increased glycogen chain lengths, suggesting interdependency
between branching and phosphorylation. Similarly, inmany plant
starches, elevated phosphate levels are associated with a low
degree of branching (Blennow et al., 1998, 2000). The mecha-
nisms underlying this association have yet to be elaborated, in
starch and in glycogen. Possibly, branching is regulated through
C6 esterification. Gradual isoamylolysis ofWT glycogen revealed
that glycogen molecules from all sizes apparently differ in their
average side chain lengths, those with shorter chains carrying
less G6P residues. These results are consistent with data
obtained by gradual a-amylolysis. Higher C6 phosphorylation
in the more central regions of glycogen molecules points to a
role during the early stages of glycogen synthesis, probably to
avoid excessive packing through high branching. LD leads to
accumulation of C6 phosphorylation over many rounds of syn-
thesis and degradation and thereby to a higher proportion of
less branched molecules. At one point, molecules with too-
long side chains are likely to become insoluble and precipitate
as Lafora bodies.
Glycogen is an osmotically largely inert repository of glucose
and is also the depot for rapid clearance and storage of excess
circulating glucose as controlled by insulin. In insulin resistance,
e.g., in type II diabetes and obesity, disturbed glycogen synthe-
sis is a major component of the impaired insulin response
(Abdul-Ghani and DeFronzo, 2010; Shulman et al., 1990). While
much has been uncovered of the signaling pathways from insulin
to the enzymes of glycogen synthesis and breakdown, the
mechanisms of impaired glycogen formation in insulin resistance
remain poorly defined. Our work corrects the current view
ascribing glycogen phosphorylation to a mere enzymatic error
and suggests that (de)phosphorylation of glycogen is an impor-
tant physiological process crucial to proper glycogen construc-
tion. This unstudied area is therefore a potential source of
important insights into glycogen synthesis regulation. Certainly,
it is crucial to understanding LD, one of the severest forms of
neurodegeneration and epilepsy, arguably one of the severest
diseases of adolescence.EXPERIMENTAL PROCEDURES
Enzymes, Chemicals, and Tissues
UDP-[U-14C]glucose (300–350 mCi/mmol) and [32P]orthophosphate (900–
1,100 mCi/mmol) were purchased from American Radiolabeled Chemicals
and Perkin Elmer, respectively. For synthesis of [b-32P]UDPglucose, see
Tagliabracci et al. (2011). Rabbit muscle GS and GP, rabbit liver glycogen,
G6P, and UDPglucose were obtained from Sigma. Mouse tissues are from
9- to 12-month-old animals and rabbit skeletal muscle from adult male
rabbits. All animal procedures were approved by the Toronto Centre for
Phenogenomics Animal Care Committee. Muscle GS knockout mouse tis-
sues were a kind gift of Dr. P.J. Roach (Department of Biochemistry and
Molecular Biology, Indiana University School of Medicine). Rhizomes
from Curcuma longa L. were purchased from a local store and frozen until
use.
Plants
Plants from Arabidopsis thaliana Col-0 and a homozygous GWD-deficient
mutant (Sex1-8; Ritte et al., 2006) were grown under controlled conditions
(14 hr light [100 mmol quanta m2 s1; 22C], 10 hr dark [17C]; 70% RH).CStarch Isolation
Native transitory starch from Arabidopsis leaves and reserve starch from cur-
cuma rhizomes were isolated according to Ko¨tting et al. (2005), with some
modifications (Supplemental Experimental Procedures).
Glycogen Isolation
Glycogen was isolated according to Tagliabracci et al. (2008), dissolved in
H2O, and stored frozen until use. Where stated, glycogen was five times
precipitated in 66.6% ethanol [v/v] and 5.4 mM LiCl for 1 hr at 20C each,
collected by centrifugation (10 min at 20,0003 g), dissolved in water, and rep-
recipitated. Rabbit glycogen was additionally washed five times using a mem-
brane (regenerated cellulose) filter (100 kDa cutoff). In the retentate, recovery
of glycogen exceeded 90%. Glucose-based glucosyl 6-phosphate contents
(see below) were not altered by glycogen purification. Similar results were
obtained with mouse glycogen.
Determination of Glycogen Molar Mass Distributions by FFF-MALLS
Glycogen samples were equilibrated with the eluent of FFF (0.1 M sodium
nitrate containing 0.05% [w/v] sodium azide) by repeated washings using a
membrane filter (five times; 10 kDa cutoff). Subsequently, glycogen (if not
stated otherwise 180 mg each, dissolved in 220 ml eluent) was injected into a
symmetrical FFF device (F-1000, regenerated cellulose as separation mem-
brane, cutoff 10 kDa; FFFractionation Inc., Salt Lake City, UT, USA). Following
2 min equilibration, a constant channel flow of 1 ml min1 and a linear cross-
flow gradient (0–5min, 3 ml min1; 30min, 0.2 ml min1) were used. Light scat-
tering and concentrations were monitored by a multiangle DAWN DSP laser
photometer (He-Ne-laser; WTC, Santa Barbara, CA, USA) and an Optilab
DSP Interferometric Refractometer (WTC), respectively. Molar mass distribu-
tion and average molar mass were calculated by using the ASTRA software
(version 4.75, WTC; extrapolation by Debye, first order). For biological replica,
mean values (and SEM) of the RI and molar mass data, respectively, were
calculated at a given elution volume.
Debranching and Chain Pattern Analysis
Glycogen was exhaustively (completely) debranched by overnight incubation
(3 mMNH4OAc [pH 5], 37
C). Total volume, glycogen amount, and isoamylase
(Sigma, Pseudomonas) activity were 100 ml, 200 mg, 500 U for the experiment
in Figure 2C (debranching method 1), and 50 ml, 10 mg, 50 U for Figures 6C and
6D (debranching method 2). Following heating (4 min at 95C) and centrifuga-
tion (10 min; 20,000 3 g), equal glucose equivalents were applied to HPAEC-
PAD (Supplemental Experimental Procedures). For each DP, relative peak
areas were determined. For biological replica, mean values and standard
deviation (SD) were calculated. Debranching was complete since doubling
of isoamylase activity during incubation did not alter the resultant chain length
profile.
Gradual Enzymatic Glycogen Degradation
a-Amylolysis
In a final volume of 1,620 ml, glycogen (3.6 mg) was incubated at 37C with
0.65 U a-amylase (Roche, pig pancreas) in 28.3 mMNaOAc (pH 7). At intervals
(13, 30, and 80 min), aliquots were heated (10 min at 95C). As control (0 min),
a-amylase was omitted. To separate glycogen-derived fragments (filtrate)
from larger-sized glycogen (retentate), all samples were applied to membrane
filtration (10 kDa cutoff) and washed six times with water. In the retentate, both
glycogen (as glucose equivalents) and glucosyl 6-phosphate residues were
quantified following acid hydrolysis (method H2, described below). In addition,
equal amounts (120 mg) of the glycogen (retentate) were subjected to FFF-
MALLS. Results were confirmed by an additional independent experiment.
Isoamylolysis
In a final volume of 438 ml, glycogen (3.6 mg) was incubated with 3,000 U iso-
amylase at 37C in water. At intervals (2, 10, 40, and 90 min, overnight),
aliquots were heated (5 min at 95C). As control (0 min), isoamylase was
omitted. Glucan chains released and the larger-sized glycogen were sepa-
rated as described above, but a 30 kDa filter was used. Retentate was
analyzed as described above. Overnight digest was almost complete, as
less than 3% of the initial glycogen was found in the respective retentate. In
addition, glycogen retained was analyzed by FFF-MALLS (120 mg glucose
equivalents each), and chain length pattern was determined after completeell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc. 765
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experiment.
Acid Hydrolysis of Starch or Glycogen
Interglucose bondswere completely cleaved by acid hydrolysis. For hydrolysis
with HCl (acid hydrolysismethod 1; H1), 0.7MHCl, 3 hr, 95C, and subsequent
neutralization with KOHwere used. For hydrolysis with TFA (hydrolysis method
2; H2), 2 M TFA, 3 hr, 100C, with TFA subsequently removed by vacuum
centrifugation. These methods do not affect C6 phosphate esters (Haebel
et al., 2008). Completeness of hydrolysis was ensured (longer hydrolysis did
not change glucose concentration in the hydrolysate). Carbohydrate concen-
tration during hydrolysis never exceeded 1 mg/ml. The stability of G6P was
tested by using a G6P standard; G6P recovery exceeded 95%.
Phosphoglucan Enrichment after Exhaustive Amylolysis
For details, see the Supplemental Experimental Procedures. Briefly, purified
curcuma starch and glycogen from rabbit skeletal muscle or Epm2a–/–
mouse liver were exhaustively (completely) digested with a mixture of
a-amylase and amyloglucosidase (see ‘‘Details of Amylolysis and Phospho-
Oligoglucan Preparation’’ in the Supplemental Experimental Procedures).
Phosphoglucans were enriched by anion exchange chromatography (QFF
Sepharose) using separate columns for each polyglucan sample. Fractions
eluted at stepwise increasing NH4OAc concentrations (pH 7.0) were lyophi-
lized, and dissolved in water, and following appropriate acid hydrolysis
glucosyl residues, total phosphate and C6 phosphate were quantified. In
addition, enrichment was monitored (Figure S2) after being established using
curcuma starch (tested by HPAEC-PAD and 31P-NMR [Figure S2 and
Supplemental Experimental Procedures]). For all polyglucans, compounds
eluting between 20 and 200 mM NH4OAc contained the majority of the
6-phosphoglucosyl residues. For NMR spectroscopy, enriched phosphoglu-
cans derived from Epm2a–/– mouse liver glycogen (340 mg), rabbit muscle
glycogen (150 mg), and curcuma starch (200 mg) were dissolved in
600 ml D2O.
NMR Spectroscopy
All NMR measurements were run at Bruker 600 MHz spectrometers at 300 K
using sample tubes having 5 mm diameter and D2O as solvent. Total phos-
phate concentrations of phosphoglucans were 6 mM (curcuma starch),
0.5 mM (Epm2a–/– mouse liver glycogen), and 2 mM (WT rabbit muscle
glycogen). For details, see the Supplemental Experimental Procedures.
Glucose Determination
Following acid hydrolysis of starch or glycogen (see above), glucose was
quantified enzymatically (Lowry and Passonneau, 1972).
G6P Assay
Following acid hydrolysis, aliquots of the hydrolysates containing up to
30 nmol glucose and external standards were applied to enzymatic G6P deter-
mination and NADPH cycling (Figure 3). The method is based on Gibon et al.
(2002) but modified for hydrolyzed polyglucans. Since G6P dehydrogenase
possesses intrinsic glucose dehydrogenase activity (Horne et al., 1970), high
glucose levels can lead to an error. The assay was optimized to reliably
determine G6P in the presence of >105-fold excess glucose (Supplemental
Experimental Procedures). All measurements were in triplicates. C6 phosphor-
ylation was calculated as G6P related to the glucose content of the hydroly-
sate. Hydrolysis methods H1 and H2 resulted in indistinguishable G6P
contents. Prior to acid hydrolysis, glycogen samples lacked detectable G6P
amounts.
Laforin-Mediated Hydrolysis of Glucosyl 6-Phosphates
In a final volume of 75 ml (containing 100 mM NaOAc, 50 mM each bisTris and
Tris, 4 mMDTT [pH 6.5]), 85 mg glycogen from Epm2a/mouse skeletal mus-
cle was incubated at 37C for times indicated with 250 U isoamylase and
laforin (equivalent to 0.3 mU when acting on p-nitrophenylphosphate). Where
indicated, glycogen or enzymes were omitted as control experiments and
replaced by water and buffer, respectively. Subsequently, all samples were
heated (5 min, 95C) and subjected to acid hydrolysis (H1). Glucose and
G6P were determined as described above.766 Cell Metabolism 17, 756–767, May 7, 2013 ª2013 Elsevier Inc.GS-Mediated Glucosyl Transfer to Glycogen
The assay followed Tagliabracci et al. (2011) with some modifications.
Briefly, the reaction mixture of 100 ml consisting of 50 mM Tris-HCl (pH 8.0),
10 mg/mL rabbit liver glycogen, 6.7 mM G6P, 5 mM EDTA, 12.5 mM KF,
1.0 mM [b-32P]UDPglucose (5 3 106 cpm) or 1.0 mM UDP-[U-14C]glucose
(7 3 104 cpm), and 1.2 mg rabbit muscle GS or protein extract from mouse
skeletal muscle (100 mg total protein) was incubated at 30C for 30 min except
where stated. Incubation was terminated either by boiling or by adding 2 vol-
umes of 100% ethanol. Immediately before either termination, KH2PO4 (final
concentration 50 mM) was added. Mixtures were brought to 66% [v/v] ethanol
plus 10 mM LiCl and placed at 20C for >1 hr. Glycogen was collected by
centrifugation (20 min; 16,5003 g), dissolved in H2O, and purified by a Sepha-
dex G-50 spin column (GEHealthcare; Niederwanger et al., 2005) following the
manufacturer’s instructions. In some experiments, gel filtration was repeated.
The glycogen samples (300 mg) were mixed with Laemmli sample buffer,
boiled, and subjected to SDS-PAGE using a 10% [w/v] T separation gel. Sub-
sequently, the slab gel was dried and exposed to X-ray film. In some cases, an
aliquot of the glycogen (before gel filtration) was digested with 0.3 mg/ml amy-
loglucosidase in sodium acetate buffer (0.2 M [pH 4.8], overnight, 37C), and
equal amounts of glucose equivalents of the hydrolyzed sample were loaded
onto SDS-PAGE gel. The mixture of 32P-labeled UDP and UDPglucose was
obtained by collecting the low-molecular-weight fraction obtained by gel
filtration of glycogen that had been elongated by GS in the presence of
[b-32P]UDPglucose (Supplemental Experimental Procedures).
Statistical Analyses
Significance of mean values derived from biological replicates (n as indicated)
was tested using the t test. Significance levels were as follows: *a < 0.05,
**a < 0.01, ***a < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.cmet.2013.04.006.
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